Notícias e Atividades da Nitrase Therapeutics

Veja o organograma con seus 7 executivos principais

Biografias mais buscadas da Nitrase Therapeutics

• Irene Griswold-Prenner, Chief Executive Officer and Chief Scientif...
• Perry Karsen, Director
• Henrijette Richter, Director

Criar um alerta
para seguir os movimentos de executivos da Nitrase Therapeutics.

Nitrase Therapeutics possui 2.341 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Johnson & Johnson Innovative Medicine DIA (Estados Unidos).

Popular M&A news in Biotecnologia

• Biolinq acaba de anunciar uma arrecadação de fundos de 100 milhões de dólares. (publicado em 23 de abril de 2025).
• Glycomine acaba de anunciar uma arrecadação de fundos de 115 milhões de dólares. (publicado em 22 de abril de 2025).
• Attovia Therapeutics acaba de anunciar uma arrecadação de fundos de 90 milhões de dólares. (publicado em 21 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics
• Steven Gillis - Chairman of the Board da VBI Vaccines

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Nitrase Therapeutics

• Nitrase Therapeutics Presents Preclinical Data from Multiple Studies Demonstrating Its Antibody Prevents Pathological Spread of Parkinson’s Disease in an Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference
• Nitrase Therapeutics Unveils Protein with Newly Characterized Enzymatic Function Involved in the Pathogenesis of Parkinson’s Disease
• Nitrase Therapeutics Presents Preclinical Data Demonstrating Antibody Prevents Spread of Pathology of Parkinson’s Disease at SfN’s Neuroscience 2024 Scientific Congress
• Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference
• Nitrase Therapeutics Announces Presentation at the SFN Neuroscience 2023 Annual Meeting
• Nitrase Therapeutics Announces Publication in the Journal of Biological Chemistry on the Role of Tyrosine Nitration in Cell Signaling and Cancer Biology
• Nitrase Therapeutics Presents Preclinical Data on the Role of Enzymatic Nitration in Oncology at the American Association for Cancer Research Annual Meeting
• Nitrase Therapeutics Presented New Findings on the Role of Synuclein Nitrase in Alpha Synuclein Nitration and Aggregation, as well as Motor Dysfunction at the 2023 Alzheimer's & Parkinson's Diseases (AD/PD) Conference
• Nitrase Therapeutics to Present at the 2023 American Association for Cancer Research Annual Meeting
• Nitrase Therapeutics Presented Data on the Importance of Synuclein Nitrase on the Synaptic Activity of Differentiated Dopaminergic Neurons at the Society for Neuroscience (SFN) Conference
• View more press releases Close

Redes sociais sobre Nitrase Therapeutics

• Nitrase Therapeutics na Wikipedia, Google News e Yahoo Finance
• Nitrase Therapeutics na LinkedIn, Twitter e YouTube